ArticleThe Lancet regional health. Europe2026

Development and validation of the NEOS2 score for prediction of long-term outcomes and improvement after first-line immunotherapy in patients with anti-NMDAR encephalitis: an international cohort study.

Juliette Brenner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.